Samantha Truex
InvestorBoard Member at Avalo Therapeutics
Cambridge, Massachusetts
Writes $10M β $50M checks Β· typically $25M
About
CEO of Oblenio Bio and CEO-in-Residence at Aditum Bio. Previously founding CEO of Upstream Bio, CEO of Quench Bio, COO of Synlogic, and CBO for Padlock Therapeutics. Held VP of Corporate Development role at Biogen leading transactions and serving as program executive for marketed products. Also has corporate development experience at Genzyme and Chiron Diagnostics.
Experience
- Oblenio BioCEO of Oblenio Biocurrent2025 β presentCambridge, MA
- Avalo TherapeuticsBoard Member, Chair of Nom & Gov Committee, Member Audit Committeecurrent2024 β present
- ArtiosChair of the Board of Directorscurrent2022 β present
- Upstream BioChief Executive Officer2021 β 2024Waltham, Massachusetts, United States
- HotSpot Therapeutics, Inc.Member of the Board; Chair of Audit Committee2018 β 2022Cambridge, MA
- Quench BioCEO2018 β 2021Cambridge, MA
- Synlogic TherapeuticsCOO and Head of Corporate Development2016 β 2017Cambridge, MA
- Padlock Therapeutics, Inc.Chief Business Officer2014 β 2016Cambridge, MA
- BiogenVP Corporate Development2013 β 2014Cambridge, MA
- BiogenVP, Program Executive for Fampyra2012 β 2013Cambridge, MA
- BiogenVice President, Business Development2010 β 2012
- BiogenSr. Director, Head of Product and Commercial Development for Hemophilia2008 β 2010
- BiogenSr. Director, Corporate Development2006 β 2008
- GenzymeDirector, Business Development1998 β 2006
- Chiron CorporationAssociate, Business Development1997 β 1998
- Health AdvancesAssociate Consultant1995 β 1997
Education
- The Tuck School of Business at DartmouthMBA1993 β 1995
- Thayer School of Engineering at DartmouthBachelor of Engineering (B.E.), Biomedical Engineering1992 β 1993
- Dartmouth CollegeBachelor of Arts (B.A.), Biology1988 β 1992
- high school
- high school
Skills & more
Mergers & Acquisitions14Corporate Development12Business Development12Biotechnology26Commercialization9Biopharmaceuticals23Drug Development7Cross-functional Team Leadership6
From Samantha's professional profile.
Same school
Also attended The Tuck School of Business at Dartmouth149
John McCulloughInvestor at OpenView Venture PartnersCarley PhillipsPrincipal at GreycroftM.G. ThibautFormer Chief Financial Officer at Drone Deploy at Scale Venture PartnersLiam DonohueInvestor at .406 VenturesGraham BrooksPartner at .406 VenturesJoanna Skoler GilmanChief Marketing and Communications Officer at .406 Ventures
+ 143 more
Also attended Thayer School of Engineering at Dartmouth11
Eric FettVice President at NGP CapitalHaley LeversedgeInvestor at Silversmith Capital PartnersErrik AndersonGeneral Partner at 82VSBen HemaniFounding Partner at Bison VenturesSarah HammerAssociate at Rhapsody Venture PartnersEricka Tamayo-GuevaraAnalyst at The Engine Ventures
+ 5 more
Also attended Dartmouth College310
Tomasz TunguzFounder & General Partner at Theory VenturesScott SandellExecutive Chairman & Chief Investment Officer at NEAJames DetweilerVP of Investments at Felicis VenturesBen RobbinsInvestor at GV (Google Ventures)Mounisha AnumoluInvestor at GV (Google Ventures)Ren RileyAdvisor at Oak Investment Partners
+ 304 more
Shared employers
Also worked at Artios3
Also worked at Genzyme76
Christine AylwardFounder & Managing Partner at Magnetic VenturesAlan WaltsVenture Partner at Advent Life SciencesMatt VineSenior Associate at RRE VenturesWalter OlesiakOperating Partner at RDiscoveryRamy RiadPresident, Plasma-Derived Therapies Business Unit at Takeda VenturesCarlos Garcia-EcheverriaVenture Partner at Ysios Capital
+ 70 more
Also worked at Chiron Corporation9
Annalisa D'AndreaVenture Partner at Longwood FundAlexia PerouseManaging Partner and CEO at iBionextDion MadsenPartner at Amplitude Venture CapitalKristin Torres MowatPartner at Health Velocity CapitalPeter ThompsonGeneral Partner at OrbiMedRebecca LuciaPartner at 5AM Ventures
+ 3 more
Colleagues at Avalo Therapeutics
Aaron Kantoff
Board Member at Avalo Therapeutics
Ashley Ivanowicz
Senior Vice President, Human Resources at Avalo Therapeutics
Chris Sullivan
Chief Financial Officer at Avalo Therapeutics
Colleen Matkowski
Senior Vice President, Global Regulatory Affairs and Quality Assurance at Avalo Therapeutics
Dino C. Miano
Senior Vice President, CMC and Technical Operations at Avalo Therapeutics
Garry A. Neil
Chief Executive Officer at Avalo Therapeutics
Gilla Kaplan
Board Member at Avalo Therapeutics
Jennifer Riley
Chief Strategy Officer at Avalo Therapeutics





















)

















